K

KBI Biopharma

CDMO delivering cell line development

Research Associate/Senior Research Associate

Bioprocess & BiomanufacturingConfirmed live in the last 24 hours
Full-timeBoulder, CO, USA$55k - $85kIn-person

About the Job

Requirements

  • Hands-on laboratory experience with analytical techniques.
  • Strong data analysis and problem-solving skills.
  • Ability to troubleshoot experiments.
  • Effective technical writing and communication skills.
  • Ability to work in team environments and interact with clients.
  • Research Associate I requires a bachelor's degree in Chemistry, Biochemistry, or a related field and 0+ years of experience.
  • Research Associate II requires a bachelor's degree with 2+ years of experience or a master's degree with 0+ years of experience.
  • Senior Research Associate requires a bachelor's degree with 4+ years of experience or a master's degree with 2+ years of experience.

Responsibilities

  • Perform testing and method qualification of biotherapeutic samples using analytical techniques such as high-performance liquid chromatography, mass spectrometry, sodium dodecyl sulfate-polyacrylamide gel electrophoresis, sodium dodecyl sulfate capillary gel electrophoresis, enzyme-linked immunosorbent assay, ultraviolet-visible spectroscopy, and other biophysical methods.
  • Execute experimental protocols and interpret data.
  • Analyze experimental data and document results in technical reports and electronic lab notebooks.
  • Troubleshoot experiments and support process improvements.
  • Present findings to internal teams and clients.
  • Maintain familiarity with scientific literature.
  • Ensure proper handling, labeling, and disposal of chemicals and hazardous materials.
  • Contribute to team-based problem solving and continuous improvement.

About the Company

KBI Biopharma

CDMO delivering cell line development

KBI Biopharma is a CDMO that accelerates the development of biological medicines by providing rapid cell line generation and process development for preclinical programs. It uses established mammalian and microbial expression systems (such as CHO K1, CHO S, CHO DG44, HEK293, and DXB11 E. coli) to create production cell lines and develop integrated manufacturing processes. Compared with competitors, it wins on speed, end-to-end capability, and flexibility across multiple platforms to move projects quickly from discovery to preclinical milestones for a diverse client base. Its goal is to reduce risk, shorten development timelines, and expand global access to life-saving biologic therapies.

Company size
1,001-5,000
Company stage
Late Stage VC
Total funding
$109.5M
Headquarters
Durham, NC
Founded
1996

Recently Posted Jobs

Explore more opportunities at KBI Biopharma

See more jobs